{"id":"NCT01940341","sponsor":"Gilead Sciences","briefTitle":"Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen","officialTitle":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD Versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-12","primaryCompletion":"2015-09-30","completion":"2022-08-31","firstPosted":"2013-09-12","resultsPosted":"2017-03-30","lastUpdate":"2023-09-25"},"enrollment":426,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["HBeAg-negative Chronic Hepatitis B"],"interventions":[{"type":"DRUG","name":"TAF","otherNames":["Vemlidy®","GS-7340"]},{"type":"DRUG","name":"TDF","otherNames":["Viread®"]},{"type":"DRUG","name":"TAF Placebo","otherNames":[]},{"type":"DRUG","name":"TDF Placebo","otherNames":[]}],"arms":[{"label":"TAF 25 mg","type":"EXPERIMENTAL"},{"label":"TDF 300 mg","type":"ACTIVE_COMPARATOR"},{"label":"Open-label TAF","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to compare the efficacy, safety, and tolerability of tenofovir alafenamide (TAF) versus tenofovir disoproxil fumarate (TDF) in treatment-naive and treatment-experienced adults with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Hepatitis B Virus (HBV) DNA < 29 IU/mL","timeFrame":"Week 48","effectByArm":[{"arm":"TAF 25 mg","deltaMin":94,"sd":null},{"arm":"TDF 300 mg","deltaMin":92.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":12},"locations":{"siteCount":105,"countries":["United States","Australia","Canada","France","Hong Kong","India","Italy","Japan","New Zealand","Poland","Romania","Russia","South Korea","Spain","Taiwan","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["39327857","37771546","37561058","30038044","29933096","29756595","28404092"],"seeAlso":["https://www.gileadclinicaltrials.com/study/?id=GS-US-320-0108"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":285},"commonTop":["Headache","Nasopharyngitis","Upper respiratory tract infection","Arthralgia","Cough"]}}